- Trials with a EudraCT protocol (20)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
20 result(s) found for: Cataracts.
Displaying page 1 of 1.
EudraCT Number: 2006-002945-36 | Sponsor Protocol Number: TRA108132 | Start Date*: 2007-03-12 | |||||||||||
Sponsor Name:GlaxoSmithKline Research and Development Ltd | |||||||||||||
Full Title: LENS – Long-term Eltrombopag ObservatioNal Study - A long term observational ocular safety study in adults who have received study medication (SB-497115-GR / eltrombopag olamine or placebo) in a ph... | |||||||||||||
Medical condition: Long-term ocular safety specifically related to cataract formation in subjects who have previously participated in a phase II or III protocol for eltrombopag (SB-497715-GR) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) SE (Completed) ES (Completed) CZ (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-015037-78 | Sponsor Protocol Number: CAT-UV-09 | Start Date*: 2009-10-27 | |||||||||||
Sponsor Name:DR. PAOLO MORA | |||||||||||||
Full Title: PERI-OPERATIVE PROPHYLAXIS FOR CATARCT SURGERY IN UVEITIC PATIENTS: A MULTICENTRIC, PROSPECTIVE, RANDOMISED STUDY | |||||||||||||
Medical condition: PATIENTS AFFECTED BY CATARCT WITH HISTORY OF UVEITIS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003277-34 | Sponsor Protocol Number: T2380-PIV-017 | Start Date*: 2018-01-15 | ||||||||||||||||
Sponsor Name:Laboratoires Théa | ||||||||||||||||||
Full Title: Phase IV, open-label, randomized clinical trial to evaluate the effects of Fydrane® and standard topical mydriatics and anaesthetics protocol on ocular surface after cataract surgery. | ||||||||||||||||||
Medical condition: Cataracts | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005684-26 | Sponsor Protocol Number: Version_1_10072006 | Start Date*: 2007-09-06 | |||||||||||||||||||||
Sponsor Name:Universitätsklinik für Augenheilkunde und Optometrie, AKH Wien | |||||||||||||||||||||||
Full Title: Identification and Quantification of Cytokines in Anti-VEGF Therapy and Genetic Risk Factors in Exsudative Age-related Macular Degeneration | |||||||||||||||||||||||
Medical condition: Exsudative age-related macular degeneration (AMD), cataract, macular pucker | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: AT (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-002138-63 | Sponsor Protocol Number: 044-SI | Start Date*: 2016-12-06 | ||||||||||||||||
Sponsor Name:SOCIETÀ INDUSTRIA FARMACEUTICA ITALIANA (SIFI) SPA | ||||||||||||||||||
Full Title: A prospective, multi-center, controlled, double-blind study to evaluate the efficacy and tolerability of a steroid/antibiotic associated treatment following cataract extraction by means of phaco-em... | ||||||||||||||||||
Medical condition: Post-surgery ocular inflammation and infection after cataract extraction by means of phaco-emulsification and intra-ocular lens implantation. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-003709-15 | Sponsor Protocol Number: 20050219 | Start Date*: 2006-11-08 | ||||||||||||||||
Sponsor Name:Swedish Orphan Biovitrum AB (publ) | ||||||||||||||||||
Full Title: A Double-Blind, Randomized, Placebo-controlled Study of Two Different Schedules of Palifermin (Pre- and Post Chemotherapy and Pre-Chemotherapy only) for Reduction in Severity of Oral Mucositis in S... | ||||||||||||||||||
Medical condition: Oral Mucositis Induced by High Dose Chemotherapy Cataract development associated with palifermin administration | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) HU (Completed) CZ (Completed) IE (Completed) AT (Completed) BE (Completed) FI (Completed) SE (Completed) DE (Completed) DK (Completed) IT (Completed) NL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-001416-11 | Sponsor Protocol Number: PROCEF/EYE | Start Date*: 2018-07-12 |
Sponsor Name:Consorci Mar Parc de Salut de Barcelona (Parc de Salut MAR) | ||
Full Title: Assessment of macular thickness after non-traumatic cataract surgery associated to intracamerular injection of Cefuroxima prepared at the hospital vs Prokam. | ||
Medical condition: Pseudophakic macular edema | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2023-001104-33 | Sponsor Protocol Number: AT0071002 | Start Date*: 2023-12-22 | |||||||||||
Sponsor Name:Applied Therapeutics Inc. | |||||||||||||
Full Title: A Sequential, Two-Part Study to Evaluate the Clinical Benefit, Safety, Pharmacokinetics, and Pharmacodynamics of AT-007 in Pediatric Patients with Classic Galactosemia (CG) | |||||||||||||
Medical condition: Galactosemia | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000286-36 | Sponsor Protocol Number: LEVODESA_04-2017 | Start Date*: 2018-08-28 | |||||||||||
Sponsor Name:NTC s.r.l. | |||||||||||||
Full Title: An international, multicenter, randomized, blinded-assessor, parallel-group clinical study comparing eye drops of combined LEvofloxAcin + DExamethasone foR 7 days followed by dexamethasone alone fo... | |||||||||||||
Medical condition: Prevention and treatment of inflammation and prevention of infection associated with cataract surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-001362-32 | Sponsor Protocol Number: Prot-06032007 | Start Date*: 2008-03-03 | |||||||||||
Sponsor Name:University Hospitals Of Leicester NHS Trust | |||||||||||||
Full Title: The use of non-ionic contrast media to clear corneal scars | |||||||||||||
Medical condition: Will plan to investigate patients who would benefit from cataract surgery but whom have corneal scarring which would make surgery difficult. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-014054-14 | Sponsor Protocol Number: SILC 201109v2 | Start Date*: 2010-05-28 | ||||||||||||||||
Sponsor Name:Guys' and St Thomas' NHS Foundation Trust, Joint Clinical Trials Office | ||||||||||||||||||
Full Title: Comparison of the Safety of Intracameral Levofloxacin to intracameral Cefuroxime for the prevention of endophthalmitis in cataract surgery (SILC) | ||||||||||||||||||
Medical condition: Cataracts and endophthalmitis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-002666-47 | Sponsor Protocol Number: SOAP1 | Start Date*: 2017-11-02 | |||||||||||
Sponsor Name:Dpt. of Ophthalmology, Rigshospitalet-Glostrup | |||||||||||||
Full Title: Effect of drop-less surgery compared to topical NSAID alone and combination of steroid and NSAID on central macular thickness after cataract surgery, a randomized controlled trial | |||||||||||||
Medical condition: Postoperative cystoid macular edema following cataract surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001235-30 | Sponsor Protocol Number: MSI-1256F-302 | Start Date*: 2005-10-26 |
Sponsor Name:Genaera Corporation | ||
Full Title: A Phase 3 Multicenter, Randomized, Double-Masked, Controlled Study of Squalamine Lactate (MSI-1256F) for Injection for the Treatment of Subfoveal Choroidal Neovascularization Associated with Age-Re... | ||
Medical condition: Subfoveal Choroidal Neovascularization Associated with Age-Related Macular Degeneration | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-004431-21 | Sponsor Protocol Number: IBERICA | Start Date*: 2006-02-17 |
Sponsor Name:Fresenius Biotech GmbH | ||
Full Title: Estudio abierto, multicéntrico, aleatorio, con el objetivo de evaluar la eficacia y la seguridad de la inmunosupresión tras un primer trasplante renal cadavérico a corazón latiente basado la utiliz... | ||
Medical condition: Trasplante renal de donante cadavérico | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Completed) PT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001078-25 | Sponsor Protocol Number: H.34.04.04.07.B1 | Start Date*: 2011-11-07 | ||||||||||||||||||||||||||
Sponsor Name:National Institute of Health, National Eye Institute | ||||||||||||||||||||||||||||
Full Title: Long-term Follow-up of Patients Who Participated in the Multicenter Uveitis Steroid Treatment Trial (MUST Trial Follow-up Study). | ||||||||||||||||||||||||||||
Medical condition: Non-infectious pan, intermediate and posterior uveitis (inflammatory eye disease) | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-004058-11 | Sponsor Protocol Number: RM-493-023 | Start Date*: Information not available in EudraCT |
Sponsor Name:Rhythm Pharmaceuticals, Inc. | ||
Full Title: A Phase 3 trial of Setmelanotide (RM-493), a Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström syndrome (AS) Patients with Moderate to Severe Obesity | ||
Medical condition: Obesity and hyperphagia in patients with Bardet-Biedl Syndrome or Alström syndrome | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: FR (Completed) ES (Completed) GB (GB - no longer in EU/EEA) | ||
Trial results: View results |
EudraCT Number: 2017-002704-27 | Sponsor Protocol Number: VBP15-004-A4 | Start Date*: 2019-07-06 | |||||||||||
Sponsor Name:ReveraGen BioPharma, Inc. | |||||||||||||
Full Title: A Phase IIb Randomized, Double-blind, Parallel Group, Placebo- and Active-controlled Study with Double-Blind Extension to Assess the Efficacy and Safety of Vamorolone in Ambulant Boys with Duchenne... | |||||||||||||
Medical condition: Duchenne muscular dystrophy (DMD) | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male | ||||||||||||
Trial protocol: BE (Completed) SE (Completed) NL (Completed) CZ (Completed) GR (Completed) ES (Completed) GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-001215-37 | Sponsor Protocol Number: RG_16_211 | Start Date*: 2018-03-19 |
Sponsor Name:University of Birmingham | ||
Full Title: A pivotal, international, randomised, double-blind, efficacy and safety trial of sodium valporate in paediatric and adult patients with Wolfram Syndrome | ||
Medical condition: Wolfram syndrome | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) PL (Completed) FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-023744-33 | Sponsor Protocol Number: 2 | Start Date*: 2012-11-12 | |||||||||||
Sponsor Name:University of Rochester | |||||||||||||
Full Title: Duchenne muscular dystrophy: double-blind randomized trial to find optimum steroid regimen | |||||||||||||
Medical condition: Duchenne muscular dystrophy (DMD) | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) IT (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002309-30 | Sponsor Protocol Number: P04230 | Start Date*: 2007-06-18 | |||||||||||
Sponsor Name:Schering-Plough Research Institute, a division of Schering Corporation | |||||||||||||
Full Title: A Randomized Placebo-Controlled Efficacy and Safety Study of 1-Year Duration with High and Medium Dose Inhaled Mometasone Furoate/Formoterol Combination Formulation Compared With Formoterol and Hig... | |||||||||||||
Medical condition: Chronic Obstructive Pulmonary Disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) NL (Completed) HU (Completed) SK (Completed) EE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
